CorMedix Inc. (CRMD)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch CRMD
See up to 3 months of CRMD. The 7-day demo opens the 1M and 3M ranges and puts CRMD on your watchlist.
Start 7-day demoLatest CRMD insider trades
About CorMedix Inc. (CRMD)
CorMedix Inc. files with the SEC under CIK 0001410098 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
CRMD Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Option exercise | 2 | 97,818 | |
| Tax withholding / forfeiture | 3 | 24,924 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CRMD insider transactions (Form 4)
6144 Form 4 filings on record, the earliest from Nov 18, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Janet Dillione - Director | Option exercise | Common Stock | 48,909 | - footnote F1 | - | |
| Janet Dillione - Director | Option exercise | Phantom Stock | 48,909 | - footnote F1 | - | |
| ||||||
| Susan Blum - Officer | Tax withholding / forfeiture | Common Stock | 8,424 | $8.30 | $70K | |
 Elizabeth Hurlburt - Officer | Tax withholding / forfeiture | Common Stock | 8,076 | $8.30 | $67K | |
 Kaufman Beth Zelnick - Officer | Tax withholding / forfeiture | Common Stock | 8,424 | $8.30 | $70K | |
| Kaufman Beth Zelnick - Officer | Grant or award | Common Stock | 36,006 | $0.00 footnote F1 | - | |
| ||||||
| Elizabeth Hurlburt - Officer | Grant or award | Common Stock | 36,006 | $0.00 footnote F1 | - | |
| ||||||
| Joseph Todisco - Officer | Grant or award | Common Stock | 77,156 | $0.00 footnote F1 | - | |
| ||||||
| Susan Blum - Officer | Tax withholding / forfeiture | Common Stock | 9,767 | $7.27 | $71K | |
| Susan Blum - Officer | Grant or award | Common Stock | 72,820 | $0.00 footnote F1 | - | |
| ||||||
| Kaufman Beth Zelnick - Officer | Tax withholding / forfeiture | Common Stock | 8,803 | $7.27 | $64K | |
| Kaufman Beth Zelnick - Officer | Grant or award | Common Stock | 72,820 | $0.00 footnote F1 | - | |
| ||||||
| Elizabeth Hurlburt - Officer | Tax withholding / forfeiture | Common Stock | 10,778 | $7.27 | $78K | |
| Elizabeth Hurlburt - Officer | Grant or award | Common Stock | 93,010 | $0.00 footnote F1 | - | |
| ||||||
| Joseph Todisco - Officer | Tax withholding / forfeiture | Common Stock | 27,306 | $7.27 | $199K | |
| Joseph Todisco - Officer | Grant or award | Common Stock | 225,900 | $0.00 footnote F1 | - | |
| ||||||
| Myron Kaplan - Director | Grant or award | Common Stock | 30,453 | $0.00 footnote F1 | - | |
| ||||||
| Janet Dillione - Director | Grant or award | Common Stock | 30,453 | $0.00 footnote F1 | - | |
| ||||||
| Steven W. Lefkowitz - Director | Grant or award | Common Stock | 30,453 | $0.00 footnote F1 | - | |
| ||||||
| Alan W. Dunton - Director | Grant or award | Common Stock | 30,453 | $0.00 footnote F1 | - | |
| ||||||
| Robert A. Stewart - Director | Grant or award | Common Stock | 30,453 | $0.00 footnote F1 | - | |
| ||||||
 Gregory Scott Duncan - Director | Grant or award | Common Stock | 30,453 | $0.00 footnote F1 | - | |
| ||||||
| Janet Dillione - Director | Open-market sale | Common Stock | 10,000 | $6.88 footnote F1 | $69K | |
| ||||||
| Elizabeth Hurlburt - Officer | Tax withholding / forfeiture | Common Stock | 5,794 | $7.15 | $41K | |
| Joseph Todisco - Officer | Tax withholding / forfeiture | Common Stock | 22,665 | $6.78 | $154K | |
| Joseph Todisco - Officer | Tax withholding / forfeiture | Common Stock | 17,417 | $7.15 | $125K | |
| Joseph Todisco - Officer | Option exercise | Common Stock | 29,585 footnote F2 | $3.38 | $100K | |
| Joseph Todisco - Officer | Option exercise | Stock Option (Right to Buy Common Stock) | 29,585 | $0.00 | - | |
| ||||||
| Michael David Seckler - Officer | Grant or award | Common Stock | 133,156 | $0.00 footnote F1 | - | |
| ||||||
| Steven W. Lefkowitz - Director | Option exercise | Common Stock | 15,000 | $5.63 | $84K | |
| Steven W. Lefkowitz - Director | Option exercise | Stock Option (Right to Buy Common Stock) | 15,000 | $0.00 | - | |
| Elizabeth Hurlburt - Officer | Tax withholding / forfeiture | Common Stock | 10,895 | $12.16 | $132K | |
| Kaufman Beth Zelnick - Officer | Tax withholding / forfeiture | Common Stock | 11,333 | $12.16 | $138K | |
| Alan W. Dunton - Director | Option exercise | Common Stock | 20,000 | $4.03 | $81K | |
| Alan W. Dunton - Director | Open-market sale | Common Stock | 20,000 | $13.00 | $260K | |
| Alan W. Dunton - Director | Option exercise | Stock Option (Right to Buy Common Stock) | 20,000 | $0.00 | - | |
| Joseph Todisco - Officer | Option exercise | Common Stock | 30,000 | $4.43 | $133K | |
| Joseph Todisco - Officer | Open-market sale | Common Stock | 30,000 | $12.00 footnote F1 | $360K | |
| Joseph Todisco - Officer | Option exercise | Stock Option (Right to Buy Common Stock) | 30,000 | $0.00 | - | |
| ||||||
| Janet Dillione - Director | Option exercise | Common Stock | 19,000 | $9.55 | $181K | |
| Janet Dillione - Director | Option exercise | Common Stock | 15,000 | $5.63 | $84K | |
| Janet Dillione - Director | Open-market sale | Common Stock | 34,000 | $12.00 footnote F1 | $408K | |
| Janet Dillione - Director | Option exercise | Stock Option (Right to Buy Common Stock) | 19,000 | $0.00 | - | |
| Janet Dillione - Director | Option exercise | Stock Option (Right to Buy Common Stock) | 15,000 | $0.00 | - | |
| ||||||
| Steven W. Lefkowitz - Director | Open-market sale | Common Stock | 40,000 | $11.88 footnote F1 | $475K | |
| ||||||
| Janet Dillione - Director | Option exercise | Common Stock | 12,210 | $4.03 | $49K | |
| Janet Dillione - Director | Option exercise | Common Stock | 15,124 | $4.43 | $67K | |
| Janet Dillione - Director | Option exercise | Common Stock | 19,323 | $3.55 | $69K | |
| Janet Dillione - Director | Open-market sale | Common Stock | 46,657 | $10.00 | $467K | |
| Janet Dillione - Director | Option exercise | Stock Option (Right to Buy Common Stock) | 12,210 | $0.00 | - | |
| Janet Dillione - Director | Option exercise | Stock Option (Right to Buy Common Stock) | 15,124 | $0.00 | - | |
| Janet Dillione - Director | Option exercise | Stock Option (Right to Buy Common Stock) | 19,323 | $0.00 | - | |
| Janet Dillione - Director | Option exercise | Common Stock | 8,000 | $2.85 | $23K | |
| Janet Dillione - Director | Option exercise | Common Stock | 7,790 | $4.03 | $31K | |
| Janet Dillione - Director | Option exercise | Common Stock | 4,876 | $4.43 | $22K | |
| Janet Dillione - Director | Option exercise | Common Stock | 5,677 | $3.55 | $20K | |
| Janet Dillione - Director | Open-market sale | Common Stock | 26,343 | $9.93 footnote F1 | $262K | |
| Janet Dillione - Director | Option exercise | Stock Option (Right to Buy Common Stock) | 8,000 | $0.00 | - | |
| Janet Dillione - Director | Option exercise | Stock Option (Right to Buy Common Stock) | 7,790 | $0.00 | - | |
| Janet Dillione - Director | Option exercise | Stock Option (Right to Buy Common Stock) | 4,876 | $0.00 | - | |
| Janet Dillione - Director | Option exercise | Stock Option (Right to Buy Common Stock) | 5,677 | $0.00 | - | |
| ||||||
Item 2.02, 9.01
Item 8.01, 9.01
Item 8.01
Item 4.01
CRMD insider trading FAQ
What is the latest insider trade for CRMD?
CorMedix Inc. (CRMD) had 4 insider filings in the last 90 days, with the most recent on 2026-09-19. The full record for CRMD runs to 44 Form 4 filings, the earliest from 2024-11-18. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CRMD stock?
No insider purchases of CRMD were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling CRMD stock?
No insider sales of CRMD were filed in the last 90 days. 15 sales are on record for this company.
Where can I see CRMD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CRMD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Janet Dillione view on EDGAR
- - Susan Blum view on EDGAR
- - Elizabeth Hurlburt view on EDGAR
- - Kaufman Beth Zelnick view on EDGAR
- - Kaufman Beth Zelnick view on EDGAR
- - Elizabeth Hurlburt view on EDGAR
- - Joseph Todisco view on EDGAR
- - Susan Blum view on EDGAR
- - Kaufman Beth Zelnick view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CRMD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CRMD with a 7-day demo
- CRMD on your watchlist
- Every CRMD Form 4 filing on record
- Up to 3 months of CRMD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
